Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00066001Phase 2Completed
Phase 2, randomised trial of metronidazole in periodontitis (4 arms), sponsored by ADA Forsyth Institute. Primary endpoint: Change in mean attachment level at 24 months. Started Dec 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00066001.